Delivery Order SPE2DR25D1201-SPE2DR26FAKDK
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $16,710.14 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis pain management. The contract, issued on December 2, 2025, with completion scheduled for December 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used in orthopedic and rheumatological applications. The contract, valued at $14,689.32, is a firm fixed price delivery order with an ultimate completion date of August 1, 2025. This award represents a non-set-aside, competitively awarded contract supporting the federal medical procurement needs of military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $3,484.68 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. The contract, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis pain management. This firm fixed-price delivery order, valued at $2,057.32, represents a competitive award with no set-aside designation and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This non-set-aside, competitively awarded contract carries a ceiling value of $11,322.76 under a firm fixed price arrangement, with an ultimate completion date of August 22, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6mL, a hyaluronic acid-based joint injection used for osteoarthritis treatment. This competitively awarded, non-set-aside contract was finalized on August 18, 2025, with a ceiling value of $4,087.80 and a firm fixed price structure. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This...
- The Defense Logistics Agency (DLA) awarded a $20.86K delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. This competitive delivery order, issued on September 26, 2025, with a completion date of September 29, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the procurement of Synvisc-One Syringe 6ML, a hyaluronic acid-based joint injection used for osteoarthritis pain management. This firm fixed-price delivery order, valued at $5,893, was competitively awarded without set-aside designation and carries an ultimate completion date of December 9, 2025. The award was issued on December 8, 2025, with performance occurring at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. This firm fixed-price delivery order carries a ceiling value of $16,330.08 and is scheduled for completion by December 11, 2025. The contract was competitively awarded without set-aside designation and represents a child delivery order under...
- The Defense Logistics Agency awarded a $10,293.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. This non-set-aside contract, awarded on November 14, 2025, is scheduled for completion by November 17, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement under the company's...